Immunogenicity, antibody persistence, and safety of the 60 μg hepatitis B vaccine in hemodialysis patients: a multicenter, randomized, double-blind, parallel-controlled trial

References

• Yao Q, Duddington M. Peritoneal dialysis in China. Peritoneal Dial Int. 2014;34(Suppl 2):S29–S30.
   PubMed Web of Science ®Google Scholar
• Wang C, Sun J, Zhu B, et al. Hepatitis B virus infection and related factors in hemodialysis patients in China – systematic review and meta-analysis. Ren Fail. 2010;32(10):1255–1264.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR Recomm Rep. 2001;50(RR–5):1–43.
   Google Scholar
• Lok AS. Chronic hepatitis B. N Engl J Med. 2002;346(22):1682–1683.
   PubMed Web of Science ®Google Scholar
• Su T, Li C, Wang J, et al. [Study on risk factors of hepatitis B virus infection among patients receiving hemodialysis by multi-level statistical model analysis]. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi. 2015;36(5):510–514.
   PubMedGoogle Scholar
• Lanini S, Puro V, Lauria FN, et al. Patient to patient transmission of hepatitis B virus: a systematic review of reports on outbreaks between 1992 and 2007. BMC Med. 2009;7:15.
   PubMed Web of Science ®Google Scholar
• Edey M, Barraclough K, Johnson DW. Review article: hepatitis B and dialysis. Nephrology. 2010;15(2):137–145.
   PubMed Web of Science ®Google Scholar
• Liang X, Bi S, Yang W, et al. Epidemiological serosurvey of hepatitis B in China–declining HBV prevalence due to hepatitis B vaccination. Vaccine. 2009;27(47):6550–6557.
   PubMed Web of Science ®Google Scholar
• Elamin S, Abu-Aisha H. Prevention of hepatitis B virus and hepatitis C virus transmission in hemodialysis centers: review of current international recommendations. Arab J Nephrol Transplant. 2011;4(1):35–47.
   PubMedGoogle Scholar
• Ayub MA, Bacci MR, Fonseca FL, et al. Hemodialysis and hepatitis B vaccination: a challenge to physicians. Int J Gen Med. 2014;7:109–114.
   PubMedGoogle Scholar
• Lin S-Y, Liu J-H, Wang S-M, et al. Association of response to hepatitis B vaccination and survival in dialysis patients. BMC Nephrol. 2012;13:97.
   PubMed Web of Science ®Google Scholar
• Brown CM, Donlon S, O’Kelly P, et al. A prospective study of hepatitis B vaccination – a comparison of responders versus nonresponders. Ren Fail. 2011;33(3):276–279.
   PubMed Web of Science ®Google Scholar
• Ghadiani MH, Besharati S, Mousavinasab N, et al. Response rates to HB vaccine in CKD stages 3–4 and hemodialysis patients. J Res Med Sci. 2012;17(6):527–533.
   PubMed Web of Science ®Google Scholar
• Ramezani A, Eslamifar A, Banifazl M, et al. Efficacy and long-term immunogenicity of hepatitis B vaccine in haemodialysis patients. Int J Clin Pract. 2009;63(3):394–397.
   PubMed Web of Science ®Google Scholar
• Buti M, Viladomiu L, Jardi R, et al. Long-term immunogenicity and efficacy of hepatitis B vaccine in hemodialysis patients. Am J Nephrol. 1992;12(3):144–147.
   PubMed Web of Science ®Google Scholar
• Lemon SM, Thomas DL. Vaccines to prevent viral hepatitis. N Engl J Med. 1997;336(3):196–204.
   PubMed Web of Science ®Google Scholar
• Zuckerman JN. Protective efficacy, immunotherapeutic potential, and safety of hepatitis B vaccines. J Med Virol. 2006;78(2):169–177.
   PubMed Web of Science ®Google Scholar
• Labriola L, Jadoul M. The decades-long fight against HBV transmission to dialysis patients: slow but definite progress. Nephrol Dial Transplant. 2010;25(7):2047–2049.
   PubMed Web of Science ®Google Scholar
• Chow KM, Lo SH, Szeto CC, et al. Extra-high-dose hepatitis B vaccination does not confer longer serological protection in peritoneal dialysis patients: a randomized controlled trial. Nephrol Dial Transplant. 2010;25(7):2303–2309.
   PubMed Web of Science ®Google Scholar
• Ahmadi F, Ramezani M, Razeghi E, et al. A randomized controlled trial of two schedules of hepatitis B vaccination in predialysed chronic renal failure patients. Hepat Mon. 2012;12(5):344–348.
   PubMed Web of Science ®Google Scholar
• Grzegorzewska AE. Hepatitis B vaccination in chronic kidney disease patients: a call for novel vaccines. Expert Rev Vaccines. 2014;13(11):1317–1326.
   PubMed Web of Science ®Google Scholar
• Gasim GI, Bella A, Adam I. Immune response to hepatitis B vaccine among patients on hemodialysis. World J Hepatol. 2015;7(2):270–275.
   PubMed Web of Science ®Google Scholar
• Shouval D, Roggendorf H, Roggendorf M. Enhanced immune response to hepatitis B vaccination through immunization with a Pre-S1/Pre-S2/S vaccine. Med Microbiol Immunol. 2015;204(1):57–68.
   PubMed Web of Science ®Google Scholar
• Fabrizi F, Dixit V, Messa P, et al. Intradermal vs intramuscular vaccine against hepatitis B infection in dialysis patients: a meta-analysis of randomized trials. J Viral Hepat. 2011;18(10):730–737.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Guidelines for vaccinating kidney dialysis patients and patients with chronic kidney disease; summarized from recommendations of the Advisory Committee on Immunization Practices (ACIP). Atlanta (GA): Centers for Disease Control and Prevention; 2012.
   Google Scholar
• Stevens CE, Alter HJ, Taylor PE, et al. Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy. N Engl J Med. 1984;311(8):496–501.
   PubMed Web of Science ®Google Scholar
• Bock M, Barros E, Veronese FJ. Hepatitis B vaccination in haemodialysis patients: a randomized clinical trial. Nephrology. 2009;14(3):267–272.
   PubMed Web of Science ®Google Scholar
• Oguz Y, Doganci L, Vural A. Seroconversion rates of two different doses of hepatitis B vaccine in Turkish haemodialysis patients. Cent Eur J Public Health. 2001;9(1):44–45.
   PubMedGoogle Scholar
• Chow KM, Lo SH, Szeto CC, et al. Extra-high dose hepatitis B vaccination for peritoneal dialysis patients: a randomised controlled trial. Hong Kong Acad Med. 2012;18(Suppl 6):41–43.
   PubMedGoogle Scholar
• McNulty CA, Bowen JK, Williams AJ. Hepatitis B vaccination in predialysis chronic renal failure patients a comparison of two vaccination schedules. Vaccine. 2005;23(32):4142–4147.
   PubMed Web of Science ®Google Scholar
• Polito P, Di Lullo L, Iannacci GR, et al. [Seroconversion and immune response after anti-HBV vaccination in patients on chronic hemodialysis: comparison of two vaccines]. Giornale italiano di nefrologia: organo ufficiale della Societa italiana di nefrologia. 2011;28(5):525–530.
   PubMedGoogle Scholar
• Chow KM, Law MC, Leung CB, et al. Antibody response to hepatitis B vaccine in end-stage renal disease patients. Nephron Clin Pract. 2006;103(3):c89–c93.
   PubMed Web of Science ®Google Scholar
• Bruguera M, Rodicio JL, Alcazar JM, et al. Effects of different dose levels and vaccination schedules on immune response to a recombinant DNA hepatitis B vaccine in haemodialysis patients. Vaccine. 1990;8(Suppl):S47–S49; discussion S60–S42.
   PubMed Web of Science ®Google Scholar
• Chinese Society of Infectious Diseases CMA, Hou JL. [The guideline of prevention and treatment for chronic hepatitis B: a 2015 update]. Chin J Hepatol. 2015;23(12):888–905.
   PubMedGoogle Scholar
• CFDA. The standard guidelines for adverse reactions grading of vaccine clinical trials. China Food and Drug Administration. Available from: http://www.sda.gov.cn/WS01/CL0844/9350_5.html
   Google Scholar
• Gesemann M, Scheiermann N. Quantification of hepatitis B vaccine-induced antibodies as a predictor of anti-HBs persistence. Vaccine. 1995;13(5):443–447.
   PubMed Web of Science ®Google Scholar
• Chaves SS, Daniels D, Cooper BW, et al. Immunogenicity of hepatitis B vaccine among hemodialysis patients: effect of revaccination of non-responders and duration of protection. Vaccine. 2011;29(52):9618–9623.
   PubMed Web of Science ®Google Scholar
• Yang L, Yao J, Li J, et al. Suitable hepatitis B vaccine for adult immunization in China. Immunol Res. 2016;64(1):242–250.
   PubMed Web of Science ®Google Scholar
• Wu WL, Yan BY, Lyu JJ, et al. [Antibody persistence following primary vaccination with hepatitis B vaccine among normal and high-responder adults: a 5-year follow-up study]. Chin J Prevent Med. 2016;50(6):484–490.
   Google Scholar
• Eleftheriadis T, Pissas G, Antoniadi G, et al. Factors affecting effectiveness of vaccination against hepatitis B virus in hemodialysis patients. WJG. 2014;20(34):12018–12025.
   PubMed Web of Science ®Google Scholar
• Fabrizi F, Martin P, Dixit V, et al. Meta-analysis: the effect of age on immunological response to hepatitis B vaccine in end-stage renal disease. Aliment Pharmacol Ther. 2004;20(10):1053–1062.
   PubMed Web of Science ®Google Scholar
• Sit D, Esen B, Atay AE, et al. Is hemodialysis a reason for unresponsiveness to hepatitis B vaccine? Hepatitis B virus and dialysis therapy. World J Hepatol. 2015;7(5):761–768.
   PubMed Web of Science ®Google Scholar